These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 19004839)

  • 1. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.
    Oteo J; Diestra K; Juan C; Bautista V; Novais A; Pérez-Vázquez M; Moyá B; Miró E; Coque TM; Oliver A; Cantón R; Navarro F; Campos J;
    Int J Antimicrob Agents; 2009 Aug; 34(2):173-6. PubMed ID: 19464856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
    Naseer U; Haldorsen B; Tofteland S; Hegstad K; Scheutz F; Simonsen GS; Sundsfjord A;
    APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.
    Mora A; Blanco M; López C; Mamani R; Blanco JE; Alonso MP; García-Garrote F; Dahbi G; Herrera A; Fernández A; Fernández B; Agulla A; Bou G; Blanco J
    Int J Antimicrob Agents; 2011 Jan; 37(1):16-21. PubMed ID: 21075606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania.
    Mshana SE; Imirzalioglu C; Hain T; Domann E; Lyamuya EF; Chakraborty T
    Clin Microbiol Infect; 2011 Aug; 17(8):1279-82. PubMed ID: 21595794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C
    J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil.
    Peirano G; Asensi MD; Pitondo-Silva A; Pitout JD
    Clin Microbiol Infect; 2011 Jul; 17(7):1039-43. PubMed ID: 21722255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of extended-spectrum-β-lactamase-producing Escherichia coli isolates collected in the GERM-Vet monitoring programme.
    Schink AK; Kadlec K; Kaspar H; Mankertz J; Schwarz S
    J Antimicrob Chemother; 2013 Aug; 68(8):1741-9. PubMed ID: 23599361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.